The problem of protein aggregation is widely studied across a number of disciplines, where understanding the behaviour of the protein monomer, and its behaviour with co-solutes is imperative in order to devise solutions to the problem. Here we present a method for measu... View more
Andersen, D.C. and L. Krummen, Recombinant protein expression for therapeutic applications. Current Opinion in Biotechnology, 2002. 13(2): p. 117-123.
Matasci, M., et al., Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects. Drug Discovery Today: Technologies, 2008. 5(2): p. e37-e42.
Murphy, R.M. and A. Tsai, Misbehaving proteins: protein (mis) folding, aggregation, and stability. 2006: Springer.
Knowles, T.P., M. Vendruscolo, and C.M. Dobson, The amyloid state and its association with protein misfolding diseases. Nature reviews Molecular cell biology, 2014. 15(6): p. 384-396.
Privalov, P.L., Energetic Basis of Protein Structure. Microcalorimetry of Macromolecules: The Physical Basis of Biological Structures, 2012: p. 193-224.
Clark, E.D.B., Protein refolding for industrial processes. Current Opinion in Biotechnology, 2001. 12(2): p. 202-207.
Critical reviews in therapeutic drug carrier systems, 1992. 10(4): p. 307-377.
Braun, A., et al., Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-α) in normal and transgenic mice. Pharmaceutical research, 1997. 14(10): p. 1472-1478.
European Journal of Biochemistry, 1991. 202: p. 715-728.
Patra, A., et al., Optimization of Inclusion Body Solubilization and Renaturation of Recombinant Human Growth Hormone from Escherichia coli. Protein Expression and Purification, 2000. 18(2): p. 182-192.